Moira Chan-Yeung
Research Subjects
Moira Chan-Yeung has a total of 228 co-authors. Here are the top co-authors by number of shared publications:
Allan Becker
Section of Allergy and Clinical Immunology, Department of Pediatrics and Child Health, Manitoba Institute of Child Health, University of Manitoba, Winnipeg, MB, Canada
5 shared publications- Alexander C. Ferguson
Division of Allergy, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
4 shared publications Wade Watson
Section of Allergy and Clinical Immunology, Department of Pediatrics and Child Health, Manitoba Institute of Child Health, University of Manitoba, Winnipeg, MB, Canada
4 shared publicationsAnne DyBuncio
Occupational and Environmental Lung Disease Unit, Department of Medicine
2 shared publicationsHelen Dimich-Ward
From the Occupational and Environmental Lung Disease Unit, Department of Medicine
2 shared publicationsHelen Dimich‐Ward
Occupational and Environmental Lung Disease Unit, Department of Medicine
2 shared publications
Latest Publications
Geographical variations in the prevalence of atopic sensitization in six study sites across Canada
To cite this article: Chan‐Yeung M, Anthonisen NR, Becklake MR, Bowie D, Sonia Buist A, Dimich‐Ward H, Ernst P, Sears MR, Siersted HC, Sweet L, Van Til L, Manfreda J. Geographical variations in the prevalence of atopic sensitization in six study sites across Canada. Allergy 2010; 65: 1404–1413. Background: Geographical variations in atopic sensitization in Canada have not been described previously. This study used the standardized protocol of the European Community Respiratory Health Survey‐1 (ECRHS‐1) to investigate the distribution and predictors of atopic sensitization in six sites across Canada and to compare the results with some ECRHS‐1 centers.Methods: Adults aged 20–44 years in six study sites across Canada underwent allergy skin testing using 14 allergens (Dermatophagoides pteronyssinus, Dermatophagoides farinae) cat, cockroach, grasses (Timothy grass, Kentucky grass), molds (Cladosporium herbarium, Alternaria alternata, Aspergillus fumigatus, Penicillium), trees (tree mix, birch, Olea europea), and common ragweed.Results: The overall prevalence of atopy (skin test over 0 mm to any allergen) was 62.7%. There was significant geographical variation in the prevalence of atopy in the six study sites (lowest 55.6% [95% C.I.51.3–59.9] in Prince Edward Island, highest 66.0 [61.7–70.3] in Montreal) and of sensitization to each of the allergens tested even after adjustment for confounders. When the first eight of the nine allergens in the ECRHS were used to estimate the prevalence of atopic sensitization, the prevalence of atopy in Canada was 57% compared with 35.2% overall for centers in the ECRHS. The prevalence of atopy in Vancouver (57% [52.3–61.8]) was close to that of Portland, Oregon (52.1% [46.2–58.0]).Conclusion: There was a significant variation in atopic sensitization among different study sites across Canada. The prevalence of atopic sensitization is relatively high in Canada compared with sites in the ECRHS and this may, in part, account for the high prevalence of asthma and asthma symptoms in Canada.
Geographical variations in the prevalence of atopic sensitization in six study sites across Canada
To cite this article: Chan‐Yeung M, Anthonisen NR, Becklake MR, Bowie D, Sonia Buist A, Dimich‐Ward H, Ernst P, Sears MR, Siersted HC, Sweet L, Van Til L, Manfreda J. Geographical variations in the prevalence of atopic sensitization in six study sites across Canada. Allergy 2010; 65: 1404–1413. Background: Geographical variations in atopic sensitization in Canada have not been described previously. This study used the standardized protocol of the European Community Respiratory Health Survey‐1 (ECRHS‐1) to investigate the distribution and predictors of atopic sensitization in six sites across Canada and to compare the results with some ECRHS‐1 centers.Methods: Adults aged 20–44 years in six study sites across Canada underwent allergy skin testing using 14 allergens (Dermatophagoides pteronyssinus, Dermatophagoides farinae) cat, cockroach, grasses (Timothy grass, Kentucky grass), molds (Cladosporium herbarium, Alternaria alternata, Aspergillus fumigatus, Penicillium), trees (tree mix, birch, Olea europea), and common ragweed.Results: The overall prevalence of atopy (skin test over 0 mm to any allergen) was 62.7%. There was significant geographical variation in the prevalence of atopy in the six study sites (lowest 55.6% [95% C.I.51.3–59.9] in Prince Edward Island, highest 66.0 [61.7–70.3] in Montreal) and of sensitization to each of the allergens tested even after adjustment for confounders. When the first eight of the nine allergens in the ECRHS were used to estimate the prevalence of atopic sensitization, the prevalence of atopy in Canada was 57% compared with 35.2% overall for centers in the ECRHS. The prevalence of atopy in Vancouver (57% [52.3–61.8]) was close to that of Portland, Oregon (52.1% [46.2–58.0]).Conclusion: There was a significant variation in atopic sensitization among different study sites across Canada. The prevalence of atopic sensitization is relatively high in Canada compared with sites in the ECRHS and this may, in part, account for the high prevalence of asthma and asthma symptoms in Canada.
- 1 January 2010
- Published by Elsevier
Contributors
- 30 November 2009
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 20 (8) , 710-713
Elevated cord blood IgE is associated with recurrent wheeze and atopy at 7 yrs in a high risk cohort
There is considerable interest in identifying children at high risk for developing atopic diseases for primary prevention. This study evaluates risk factors for detectable cord blood IgE and assesses CB‐IgE in predicting asthma and other IgE‐mediated allergic diseases in children at high risk because of family history. Cord blood was obtained as part of a randomized controlled trial assessing the efficacy of an intervention program in the primary prevention of IgE‐mediated allergic diseases. CB‐IgE was measured and the degree to which this was associated with perinatal risk factors was assessed. The cohort was then evaluated for atopic disorders at 7 yrs of age to assess the predictive value of CB‐IgE. Fifty‐five (19.3%) of infants had detectable CB‐IgE (≥0.5 kU/l). Maternal atopy and birth in winter months were risk factors associated with detectable CB‐IgE. CB‐IgE was found to be significantly associated with allergic sensitization (OR 2.22; 95% CI 1.11, 4.41) and recurrent wheeze at 7 yrs (OR 2.51, 95% CI 1.09, 5.76) but not with other outcomes. CB‐IgE may be a useful measure for identifying children at high risk of atopic diseases for the purpose of primary prevention.
- 30 November 2009
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 20 (8) , 710-713
Elevated cord blood IgE is associated with recurrent wheeze and atopy at 7 yrs in a high risk cohort
There is considerable interest in identifying children at high risk for developing atopic diseases for primary prevention. This study evaluates risk factors for detectable cord blood IgE and assesses CB‐IgE in predicting asthma and other IgE‐mediated allergic diseases in children at high risk because of family history. Cord blood was obtained as part of a randomized controlled trial assessing the efficacy of an intervention program in the primary prevention of IgE‐mediated allergic diseases. CB‐IgE was measured and the degree to which this was associated with perinatal risk factors was assessed. The cohort was then evaluated for atopic disorders at 7 yrs of age to assess the predictive value of CB‐IgE. Fifty‐five (19.3%) of infants had detectable CB‐IgE (≥0.5 kU/l). Maternal atopy and birth in winter months were risk factors associated with detectable CB‐IgE. CB‐IgE was found to be significantly associated with allergic sensitization (OR 2.22; 95% CI 1.11, 4.41) and recurrent wheeze at 7 yrs (OR 2.51, 95% CI 1.09, 5.76) but not with other outcomes. CB‐IgE may be a useful measure for identifying children at high risk of atopic diseases for the purpose of primary prevention.
- 18 August 2008
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 19 (6) , 482-489
Early environmental determinants of asthma risk in a high‐risk birth cohort
Environmental exposures during early life have been suggested to have the greatest impact on childhood asthma. Our aim was to evaluate the risk factors associated with asthma at age 7 yr in a high‐risk cohort that participated in a randomized controlled study on the primary prevention of asthma. Indoor exposures were characterized before birth and at 2 weeks, 4, 8, 12, 18, and 24 months after birth and again at 7 yr. Nasal scrapings for respiratory viruses were done at the same intervals during the first 2 yr. At age 7, the children were assessed by a pediatric allergist and had allergy skin tests. Logistic regression analysis was undertaken to evaluate the effect of exposures on asthma for the entire cohort with adjustment for group allocation. In addition to the lower risk of asthma in the intervention group, we found a higher prevalence of asthma at age 7 for males, those having a positive history of asthma in mother, father, or older siblings, for children residing in Winnipeg and for atopic subjects. Upon adjustment for intervention group assignment and baseline factors, significant environmental risk factors during year 1 included dog ownership and respiratory syncytial viral infection detected at 12 months while maternal smoking was protective. Dog ownership was a significant risk factor in year 2, but highly correlated with dog ownership in year 1. Indoor environmental exposures during year 7 were not associated with asthma at age 7. Maternal smoking at year 7 was associated with a reduced risk of asthma at 7 yr. Early‐life exposures were more important determinants than those in later years. A ‘window of opportunity’ exists for intervention measures to be applied.
- 18 August 2008
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 19 (6) , 482-489
Early environmental determinants of asthma risk in a high‐risk birth cohort
Environmental exposures during early life have been suggested to have the greatest impact on childhood asthma. Our aim was to evaluate the risk factors associated with asthma at age 7 yr in a high‐risk cohort that participated in a randomized controlled study on the primary prevention of asthma. Indoor exposures were characterized before birth and at 2 weeks, 4, 8, 12, 18, and 24 months after birth and again at 7 yr. Nasal scrapings for respiratory viruses were done at the same intervals during the first 2 yr. At age 7, the children were assessed by a pediatric allergist and had allergy skin tests. Logistic regression analysis was undertaken to evaluate the effect of exposures on asthma for the entire cohort with adjustment for group allocation. In addition to the lower risk of asthma in the intervention group, we found a higher prevalence of asthma at age 7 for males, those having a positive history of asthma in mother, father, or older siblings, for children residing in Winnipeg and for atopic subjects. Upon adjustment for intervention group assignment and baseline factors, significant environmental risk factors during year 1 included dog ownership and respiratory syncytial viral infection detected at 12 months while maternal smoking was protective. Dog ownership was a significant risk factor in year 2, but highly correlated with dog ownership in year 1. Indoor environmental exposures during year 7 were not associated with asthma at age 7. Maternal smoking at year 7 was associated with a reduced risk of asthma at 7 yr. Early‐life exposures were more important determinants than those in later years. A ‘window of opportunity’ exists for intervention measures to be applied.
- 1 June 2006
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 6 (3) , 146-151
Primary prevention of childhood asthma and allergic disorders
The prevalence of asthma and allergic disorders in childhood is increasing in many parts of the world. This review focuses on recent findings with regard to environmental risk factors and their manipulation in the primary prevention of these diseases in childhood. Recent studies have failed to resolve the controversy on the subject of exposure to indoor aeroallergens and the risk of sensitization and asthma in childhood. Bronchiolitis due to respiratory syncytial virus in infancy is associated with a significant increase in risk of asthma, but not atopy. In the prevention of these diseases, the effects of breastfeeding are controversial, with studies showing a protective effect in children without allergic predisposition, but other studies showing no effect or even the potential for an increased asthma risk. A significant reduction in the prevalence of doctor-diagnosed asthma at 7 years was found in a randomized controlled multifaceted (reduction of inhaled and ingested allergens) intervention study of high-risk infants. Other intervention measures, such as an education program on how to reduce exposure, the use of probiotics, and immunization against infections, all showed some protective effects. More research is required, especially with regard to longer periods of follow-up for all current intervention studies aimed at reducing exposure, the onset and duration of intervention, and other novel intervention measures in the primary prevention of asthma and allergic diseases in childhood.
- 1 June 2006
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 6 (3) , 146-151
Primary prevention of childhood asthma and allergic disorders
The prevalence of asthma and allergic disorders in childhood is increasing in many parts of the world. This review focuses on recent findings with regard to environmental risk factors and their manipulation in the primary prevention of these diseases in childhood. Recent studies have failed to resolve the controversy on the subject of exposure to indoor aeroallergens and the risk of sensitization and asthma in childhood. Bronchiolitis due to respiratory syncytial virus in infancy is associated with a significant increase in risk of asthma, but not atopy. In the prevention of these diseases, the effects of breastfeeding are controversial, with studies showing a protective effect in children without allergic predisposition, but other studies showing no effect or even the potential for an increased asthma risk. A significant reduction in the prevalence of doctor-diagnosed asthma at 7 years was found in a randomized controlled multifaceted (reduction of inhaled and ingested allergens) intervention study of high-risk infants. Other intervention measures, such as an education program on how to reduce exposure, the use of probiotics, and immunization against infections, all showed some protective effects. More research is required, especially with regard to longer periods of follow-up for all current intervention studies aimed at reducing exposure, the onset and duration of intervention, and other novel intervention measures in the primary prevention of asthma and allergic diseases in childhood.
- 1 July 2005
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 116 (1) , 49-55
The Canadian Childhood Asthma Primary Prevention Study: Outcomes at 7 years of age
- 1 July 2005
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 116 (1) , 49-55
The Canadian Childhood Asthma Primary Prevention Study: Outcomes at 7 years of age
- Open Access
- 1 January 2004
- Published by Wiley in Canadian Respiratory Journal
- Vol. 11 (1) , 21-26
Occupational Asthma ‐‐ The Last 50 Years
It was indeed a great honour for me to be this year′s Christie Memorial Lecturer. Although I have not been fortunate enough to have had personal contact with Professor Christie, one of the greatest lung physiologists of our time, I have had the opportunity over the years of interacting with and learning from the group working in the laboratory named after him ‐ the Meakins‐Christie Laboratories ‐ as a member of the Respiratory Health Network of Centres of Excellence, Canada.
- 1 January 2004
- Published by Wiley in Canadian Respiratory Journal
- Vol. 11 (1) , 21-26
Open AccessOccupational Asthma ‐‐ The Last 50 Years
It was indeed a great honour for me to be this year′s Christie Memorial Lecturer. Although I have not been fortunate enough to have had personal contact with Professor Christie, one of the greatest lung physiologists of our time, I have had the opportunity over the years of interacting with and learning from the group working in the laboratory named after him ‐ the Meakins‐Christie Laboratories ‐ as a member of the Respiratory Health Network of Centres of Excellence, Canada.
- 1 January 2002
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 88 (1) , 52-58
Effectiveness of and compliance to intervention measures in reducing house dust and cat allergen levels
- 1 January 2002
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 88 (1) , 52-58
Effectiveness of and compliance to intervention measures in reducing house dust and cat allergen levels
- 1 January 1997
- Published by Taylor & Francis in Journal of Asthma
- Vol. 34 (4) , 305-312
Laboratory and Clinical Evaluation of a Portable Computerized Peak Flow Meter
A mini-Wright based peak flow meter (VMX Mini-Log), which stores the readings together with the time and date of each measurement, has recently been marketed but has not yet been evaluated. The accuracy, reproducibility, and interdevice variability of this instrument were investigated using a pneumotachograph connected in series as a standard. Flows from 100 to 700 L/min were generated by an explosive decompression chamber. The performance of this instrument was also tested in 20 normal subjects and in 20 patients with airflow obstruction. The accuracy of the instrument was expressed as the percentage of error, and reproducibility and interdevice variability were assessed using the coefficient of variation. In the laboratory evaluation, all devices recorded flow rates that were within +/-10% of the pneumotachograph readings at flows between 200 and 600 L/min. At the extreme flow rates of 100 and 700 L/min, the mean error was higher than 10%. The reproducibility of the VMX was within +/-5% at all the flows tested. The interdevice variability was less than 5% at flow rates between 200 and 700 L/min. When tested on normal subjects with PEF between 400 and 700 L/min, the VMX performed well. In patients with airflow obstruction, four devices had greater than 10% error. The largest error was observed in those patients with PEF below 200 L/min. The VMX Mini-Log peak flow meter is accurate and precise in the flow range between 200 and 600 L/min. Its performance, however, may be affected in subjects with airflow obstruction and PEF below 200 L/min.
- 1 January 1997
- Published by Taylor & Francis in Journal of Asthma
- Vol. 34 (4) , 305-312
Laboratory and Clinical Evaluation of a Portable Computerized Peak Flow Meter
A mini-Wright based peak flow meter (VMX Mini-Log), which stores the readings together with the time and date of each measurement, has recently been marketed but has not yet been evaluated. The accuracy, reproducibility, and interdevice variability of this instrument were investigated using a pneumotachograph connected in series as a standard. Flows from 100 to 700 L/min were generated by an explosive decompression chamber. The performance of this instrument was also tested in 20 normal subjects and in 20 patients with airflow obstruction. The accuracy of the instrument was expressed as the percentage of error, and reproducibility and interdevice variability were assessed using the coefficient of variation. In the laboratory evaluation, all devices recorded flow rates that were within +/-10% of the pneumotachograph readings at flows between 200 and 600 L/min. At the extreme flow rates of 100 and 700 L/min, the mean error was higher than 10%. The reproducibility of the VMX was within +/-5% at all the flows tested. The interdevice variability was less than 5% at flow rates between 200 and 700 L/min. When tested on normal subjects with PEF between 400 and 700 L/min, the VMX performed well. In patients with airflow obstruction, four devices had greater than 10% error. The largest error was observed in those patients with PEF below 200 L/min. The VMX Mini-Log peak flow meter is accurate and precise in the flow range between 200 and 600 L/min. Its performance, however, may be affected in subjects with airflow obstruction and PEF below 200 L/min.